December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Insulet Corporation - Common Stock (NQ:PODD)

297.91 +3.56 (+1.21%)
Streaming Delayed Price Updated: 3:22 PM EST, Jan 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Insulet Corporation - Common Stock

< Previous 1 2
...
12 13 14 15 16 17 18 19 Next >
News headline image
Are the S&P 500's Biggest Q3 Losers Next Year's Winners?
More than 70% of S&P 500 stocks finished in the red last quarter, but the broad-based selloff may be an opportunity - including for these three biggest losers. 
Via MarketBeat
Topics Artificial Intelligence Economy Stocks
News headline image
Tubeless Insulin Pump Technology Provider Insulet's CFO Resigns; Reaffirms Q3, FY23 Outlook ↗
Medical device company Insulet Corp (NASDAQ: PODD) disclosed that Wayde McMillan has decided to resign as Executive Vice President,  
Via Benzinga
News headline image
Insulet Announces CFO Transition
From Insulet Corporation
Via Business Wire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For October 2, 2023 ↗
 
Via Benzinga
News headline image
FedEx To Rally Around 19%? Here Are 10 Other Analyst Forecasts For Monday ↗
JP Morgan raised the price target for The Progressive Corporation (NYSE: PGR) from $146 to $149. JP Morgan analyst Jimmy Bhullar maintained an Overweight rating. Progressive shares fell 0.8% to close... 
Via Benzinga
News headline image
Insulet to Present Extended Real-World Evidence and Best Practices for Optimizing Care with Omnipod® 5
From Insulet Corporation
Via Business Wire
News headline image
14 Analysts Have This to Say About Insulet ↗
 
Via Benzinga
News headline image
Is It Time to Buy the S&P 500's 4 Worst-Performing Stocks This Year? ↗
The broad-market index is up but these stocks are down. 
Via The Motley Fool
Topics Stocks
News headline image
Why Insulet Stock Is Sinking Today ↗
Comments from Insulet's CEO at a major healthcare conference rattled investors. 
Via The Motley Fool
News headline image
What 12 Analyst Ratings Have To Say About Insulet ↗
 
Via Benzinga
News headline image
Insulet to Announce Third Quarter 2023 Financial Results on November 2, 2023
From Insulet Corporation
Via Business Wire
News headline image
September's Shakeout: S&P 500, Nasdaq 100 See Just 13% Of Stocks Above 50-Day Average ↗
The September market downturn is spreading like wildfire across various sectors, with only a handful of stocks managing to maintain the positive trend seen in recent months. 
Via Benzinga
Topics Stocks
News headline image
Navigating The S&P 500 Landscape: Here Are The Stocks Analysts Believe Have The Highest Potential And Biggest Downside ↗
In the middle of the AI revolution and the Federal Reserve's steadfast stance on interest rates, the stock market has seen unexpected twists and turns. Despite hopes of the U.S. 
Via Benzinga
Topics Artificial Intelligence Stocks
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
  On Tuesday, 386 stocks made new 52-week lows. 
Via Benzinga
News headline image
The 7 Most Undervalued Stocks in the Market Right Now: September 2023 ↗
Buying these undervalued stocks right now can pay off tremendously once these fundamentally solid businesses ultimately recover. 
Via InvestorPlace
News headline image
Apple Taps Seasoned Executive To Head 'Secret' Team Developing Glucose Monitoring Device - Stocks To Watch ↗
Apple Inc (NASDAQ: AAPL) has appointed Tim Millet, a seasoned executive with a background in iPhone and Mac chip technology, to oversee its secretive team dedicated to developing a noninvasive blood... 
Via Benzinga
News headline image
Is It Time to Buy the S&P 500's 3 Worst-Performing August Stocks? ↗
The S&P 500 had a rare decline last month. 
Via The Motley Fool
Topics Stocks
News headline image
Dexcom Says It Won't Be The Biggest Loser In The Weight-Loss Battle — And Shares Soar ↗
Dexcom says the popularity of GLP-1 drugs won't hurt its continuous glucose monitors. 
Via Investor's Business Daily
News headline image
The 3 Most Promising Healthcare Stocks to Own Now ↗
These top healthcare stock picks are growing revenues by over 30% due to their game-changing medical device products. 
Via InvestorPlace
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
  Friday's session saw 169 companies set new 52-week lows. 
Via Benzinga
News headline image
Why Insulet Stock Rocked the Market Today ↗
The company's leader signals a giant vote of confidence in its future. 
Via The Motley Fool
News headline image
Hovnanian Enterprises, LexinFintech Holdings And Other Big Stocks Moving Higher On Wednesday ↗
U.S. stocks traded mixed, with the Dow Jones falling around 10 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
News headline image
Why Toro Are Trading Lower By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Gainers American Rebel Holdings, Inc. (NASDAQ: AREB) shares jumped 100% to $1.7909 after the company's subsidiary Champion Safe has been bombarded with calls from safe dealers and customers looking for... 
Via Benzinga
News headline image
$1M Bet On Lyft? Check Out These 4 Stocks Insiders Are Buying ↗
Although U.S. stocks closed higher on Tuesday, there were a few notable insider trades. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
  On Tuesday, 99 stocks hit new 52-week lows. 
Via Benzinga
News headline image
Insulet Announces Full Market Release of Omnipod® 5 Automated Insulin Delivery System in Germany
From Insulet Corporation
Via Business Wire
News headline image
Morgan Stanley Maintains Equal-Weight Rating for Insulet: Here's What You Need To Know ↗
 
Via Benzinga
News headline image
Insulet to Present at Upcoming Investor Conferences
From Insulet Corporation
Via Business Wire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For August 21, 2023 ↗
 
Via Benzinga
News headline image
NVIDIA To Rally Over 80%? Here Are 10 Other Analyst Forecasts For Monday ↗
Credit Suisse lowered the price target for The Walt Disney Company (NYSE: DIS) from $126 to $122. Credit Suisse analyst Douglas Mitchelson maintained an Outperforn rating. Disney shares gained 0.4% to... 
Via Benzinga
< Previous 1 2
...
12 13 14 15 16 17 18 19 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.